No other words other than shocking, awful, and terrible. Brian Thompson, CEO of UnitedHealthcare, was murdered by gunshot around 6.45am this morning 4 December, outside the New York Hilton on Sixth ...

Wojcicki believes that the company is ‘viable’ and ‘transforming’ under her. King redirected Wojcicki from her initial corporate boilerplate-speak twice within the first few minutes back to the ...

Telehealth and Telecare Aware posts pointers to a broad range of news items. Authors of those items often use terms 'telecare' and telehealth' in inventive and idiosyncratic ways. Telecare Aware's ...

Walgreens’ disposition of VillageMD clarifies with CEO/co-founder/board chair Tim Barry’s sudden and unceremonious departure. The news dropped on Wednesday 27 November, directly into the media black ...

Thanksgiving at Steward’s former CEO Ralph de la Torre and international CEO Armin Ernst’s tables as a result. Last week, reports emerged that Federal agents served search warrants and seized mobile ...

This page is a general explanation of the differences between the terms telecare, telemedicine and telehealth as used in UK social care and health services. (See next paragraph re the USA.) The ...

The series, completed through key panels and the first issue, is being funded through a Kickstarter that so far has raised just above $6,100, exceeding its $6,000 goal. It has three days left to go, ...

Weakness in tracking how healthcare organizations are effectively mitigating ransomware Not yet assessing how healthcare organizations are adopting the ransomware-specific practices outlined in the ...

On the ‘Latest News’ page (see the menu above) we post items of news that interest us. These are done as and when we find them. The newest is at the top. If you read them regularly you will find that ...

Ali Parsa back in the news, just over one year after Babylon Health’s implosion. Babylon’s CEO/founder Ali Parsa has a new and stealthy AI-related venture called Quadrivia. It was announced, unusually ...

It’s the good, bad, and a ration of ugly this week. An under-the-radar company makes a big buy and Veradigm might finally get itself sold. DOJ drags UHG to court over Amedisys–after the election.